OPAZZUS

Welcome to the Brand page for “OPAZZUS”, which is offered here for Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; pharmaceutical preparations for the treatment of pain;.

Its status is currently believed to be active. Its class is unavailable. “OPAZZUS” is believed to be currently owned by “REGENERON PHARMACEUTICALS, INC.”